Down syndrome and the complexity of genome dosage imbalance. - PubMed - NCBI

Down syndrome and the complexity of genome dosage imbalance. - PubMed - NCBI

Nat Rev Genet. 2017 Mar;18(3):147-163. doi: 10.1038/nrg.2016.154. Epub 2016 Dec 28.

Down syndrome and the complexity of genome dosage imbalance.

Antonarakis SE1.

Author information

Abstract

Down syndrome (also known as trisomy 21) is the model human phenotype for all genomic gain dosage imbalances, including microduplications. The functional genomic exploration of the post-sequencing years of chromosome 21, and the generation of numerous cellular and mouse models, have provided an unprecedented opportunity to decipher the molecular consequences of genome dosage imbalance. Studies of Down syndrome could provide knowledge far beyond the well-known characteristics of intellectual disability and dysmorphic features, as several other important features, including congenital heart defects, early ageing, Alzheimer disease and childhood leukaemia, are also part of the Down syndrome phenotypic spectrum. The elucidation of the molecular mechanisms that cause or modify the risk for different Down syndrome phenotypes could lead to the introduction of previously unimaginable therapeutic options.

PMID:

 

28029161

 

DOI:

 

10.1038/nrg.2016.154

https://phgkb.cdc.gov/GAPPKB/phgHome.do








Last Posted: Mar 09, 2017

---

• Down syndrome and the complexity of genome dosage imbalance.  
  Antonarakis Stylianos E et al. Nature reviews. Genetics 2017 Mar (3) 147-163
• Key Findings: Frequency of Trisomy Conditions using Birth Defects Tracking Programs in the United States, 2006-2010 
• Mosaic trisomy 17 at amniocentesis: Prenatal diagnosis, molecular genetic analysis, and literature review.  
  Chen Chih-Ping et al. Taiwanese journal of obstetrics & gynecology 2016 Oct (5) 712-717
• Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.  
  Haug Shelly et al. JAMA pediatrics 2017 Feb
• Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing.  
  Xu Chenming et al. Clinical chemistry 2017 Feb
• Noninvasive prenatal testing: more caution in counseling is needed in high risk pregnancies with ultrasound abnormalities.  
  Oneda Beatrice et al. European journal of obstetrics, gynecology, and reproductive biology 2016 May 20072-5
• The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.  
  Palomaki Glenn E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Jan
• Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.  
  Manotaya S et al. Prenatal diagnosis 2016 Mar 36(3) 224-31
• Patient Perception of Negative Noninvasive Prenatal Testing Results.  
  Wittman A Theresa et al. AJP reports 2016 Oct 6(4) e391-e406
• Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.  
  Barbaro Michela et al. Journal of clinical immunology 2016 Nov
• Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.  
  Papageorghiou A T et al. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2016 Feb 47(2) 188-93
• Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies.  
  Stokowski Renee et al. Prenatal diagnosis 2015 Dec 35(12) 1243-6
• IONA test for first-trimester detection of trisomies 21, 18 and 13.  
  Poon L C et al. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2016 Feb 47(2) 184-7
• Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part I - Clinical Impact.  
  Oepkes Dick et al. Prenatal diagnosis 2016 Oct
• Screening for chromosomal abnormalities using combined test in the first trimester of pregnancy.  
  Park Soo Yeon et al. Obstetrics & gynecology science 2016 Sep 59(5) 357-66
• Survival and Surgical Interventions for Children With Trisomy 13 and 18.  
  Nelson Katherine E et al. JAMA 2016 Jul 316(4) 420-8

more